Clinical Trial Update: Comparison of Efficacy and Safety of Repaglinide Combined With Insulin NPH Versus Biphasic Human Insulin 30 Alone in Inadequately Controlled Subjects With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing repaglinide plus insulin NPH versus biphasic human insulin 30 in adults with inadequately controlled type 2 diabetes; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Biphasic Human Insulin 30 (biphasic human insulin 30)
• Repaglinide (Repaglinide)
• insulin NPH (insulin NPH)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: TERMINATED